These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33609852)

  • 41. Diaphragmatic and intercostal electromyographic activity during neostigmine, sugammadex and neostigmine-sugammadex-enhanced recovery after neuromuscular blockade: A randomised controlled volunteer study.
    Cammu G; Schepens T; De Neve N; Wildemeersch D; Foubert L; Jorens PG
    Eur J Anaesthesiol; 2017 Jan; 34(1):8-15. PubMed ID: 27902641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative Neuromuscular Blockade Monitoring: Two Pictures of Unexpected Rocuronium Effect: A Case Report.
    Leonard PA; Todd MM
    A A Case Rep; 2017 Oct; 9(7):190-192. PubMed ID: 28542054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of magnesium on the dose of rocuronium for deep neuromuscular blockade: A randomised controlled trial.
    Han J; Jeon YT; Ryu JH; Koo CH; Nam SW; Cho SI; Oh AY
    Eur J Anaesthesiol; 2021 Apr; 38(4):432-437. PubMed ID: 32890015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dexamethasone Does Not Inhibit Sugammadex Reversal After Rocuronium-Induced Neuromuscular Block.
    Buonanno P; Laiola A; Palumbo C; Spinelli G; Servillo G; Di Minno RM; Cafiero T; Di Iorio C
    Anesth Analg; 2016 Jun; 122(6):1826-30. PubMed ID: 27028777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case report: Neuromuscular block induced by rocuronium following sugammadex administration.
    Askin T; Unver S; Oguz D; Kutay K
    J Clin Anesth; 2017 Feb; 37():166-167. PubMed ID: 28235515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fast recovery of haemodynamic and ventilatory functions after sugammadex bolus following rocuronium-induced anaphylactic shock refractory to conventional treatment].
    Raft J; Leclercq M; Longrois D; Meistelman C
    Ann Fr Anesth Reanim; 2012 Feb; 31(2):158-61. PubMed ID: 22197044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
    de Boer HD; Driessen JJ; van Egmond J; Booij LH
    Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
    [No Abstract]   [Full Text] [Related]  

  • 55. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study.
    Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F
    Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report.
    Ortiz-Gómez JR; Palacio-Abizanda FJ; Fornet-Ruiz I
    Eur J Anaesthesiol; 2014 Dec; 31(12):708-9. PubMed ID: 24718022
    [No Abstract]   [Full Text] [Related]  

  • 58. Case of anaphylaxis induced by rocuronium treated with sugammadex.
    Esteves LO
    Braz J Anesthesiol; 2013; 63(6):511. PubMed ID: 24565351
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
    Hristovska AM; Duch P; Allingstrup M; Afshari A
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sugammadex and rocuronium-induced anaphylaxis.
    Baldo B
    Anaesthesia; 2012 Oct; 67(10):1174-5; author reply 1175. PubMed ID: 22950397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.